BlueStar

The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.

The pair will work on integrating Welldoc's software into Lilly's not yet released insulin pen. 

Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.

Also: Consumer survey suggests declining digital health engagement; Iran's COVID-19 app pulled from Play Store after malware accusations.

The NHS is looking to ramp up its patient data security, after signing a contract with software company Privitar for its de-identification technology.

Novo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill platform.

Samsung Health users will now have access to a new consumer-grade version of WellDoc’s digital diabetes management platform, the two companies announced this morning.

WellDoc’s digital diabetes management therapeutic BlueStar will now be available on the Solera network as a diabetes management option.

The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform.

WellDoc announced today a partnership with the American Association of Diabetes Educators (AADE), a professional membership organization of over 14,000 diabetes educators.